Microbiologic testing and outcomes of full-mouth scaling and root planing with or without amoxicillin/metronidazole in chronic periodontitis
- PMID: 20059413
- DOI: 10.1902/jop.2009.090390
Microbiologic testing and outcomes of full-mouth scaling and root planing with or without amoxicillin/metronidazole in chronic periodontitis
Abstract
Background: It has been suggested that use of systemic antibiotics should be limited to patients with specific microbiologic profiles. The main purpose of the present analysis was to study whether microbiologic testing before therapy was of value in predicting which patients would specifically benefit from adjunctive amoxicillin and metronidazole, given in the context of full-mouth scaling and root planing (SRP) within 48 hours.
Methods: This was a 6-month, single-center, double-masked, placebo-controlled, randomized longitudinal study. Fifty-one patients received full-mouth periodontal debridement, performed within 48 hours; then, 25 subjects received metronidazole, 500 mg, and amoxicillin, 375 mg, three times a day for 7 days, and 26 received a placebo (control group). Pooled microbiologic samples were taken from the deepest pocket at baseline in each quadrant before and 6 months after treatment. Six periodontal pathogens were quantified by real-time polymerase chain reaction.
Results: Forty-seven patients were followed for 6 months. After treatment, test subjects had a substantially lower mean number of persisting sites with probing depth >4 mm and bleeding on probing than did control subjects (0.4 versus 3.0; P = 0.005; month 6). Aggregatibacter actinomycetemcomitans (previously Actinobacillus actinomycetemcomitans) could not be detected in the antibiotic group after treatment. However, in the placebo group, three of six subjects positive for A. actinomycetemcomitans continued to be positive. Lower frequencies were also noted in the test group for Porphyromonas gingivalis (P = 0.013) and Tannerella forsythia (previously T. forsythensis) (P = 0.007). However, even subjects testing negative for A. actinomycetemcomitans at baseline had a significantly better primary clinical outcome if they received the active drugs. The presence of six putative periodontal pathogens (A. actinomycetemcomitans, Fusobacterium nucleatum spp., P. gingivalis, Prevotella intermedia, Treponema denticola, and T. forsythia) quantified prior to therapy was not correlated with the outcome of full-mouth SRP with or without amoxicillin and metronidazole.
Conclusion: Excellent clinical results in the antibiotics group were obtained regardless of the presence or absence of six classic periodontal periopathogens prior to treatment.
Similar articles
-
Efficacy of amoxicillin and metronidazole combination for the management of generalized aggressive periodontitis.J Periodontol. 2010 Jul;81(7):964-74. doi: 10.1902/jop.2010.090522. J Periodontol. 2010. PMID: 20214441 Clinical Trial.
-
Are there specific benefits of amoxicillin plus metronidazole in Aggregatibacter actinomycetemcomitans-associated periodontitis? Double-masked, randomized clinical trial of efficacy and safety.J Periodontol. 2013 Jun;84(6):715-24. doi: 10.1902/jop.2012.120281. Epub 2012 Aug 8. J Periodontol. 2013. PMID: 22873656 Clinical Trial.
-
Amoxicillin and metronidazole as an adjunct to full-mouth scaling and root planing of chronic periodontitis.J Periodontol. 2009 Mar;80(3):364-71. doi: 10.1902/jop.2009.080540. J Periodontol. 2009. PMID: 19254119 Clinical Trial.
-
Amoxicillin/metronidazole or scaling and root planing in the treatment of chronic periodontitis.Acta Odontol Latinoam. 2010;23(3):196-203. Acta Odontol Latinoam. 2010. PMID: 21638959 Review.
-
Microbiological response to mechanical treatment in combination with adjunctive therapy. A review of the literature.J Periodontol. 1996 Nov;67(11):1143-58. doi: 10.1902/jop.1996.67.11.1143. J Periodontol. 1996. PMID: 8959563 Review.
Cited by
-
Microbial profiles at baseline and not the use of antibiotics determine the clinical outcome of the treatment of chronic periodontitis.Sci Rep. 2016 Feb 1;6:20205. doi: 10.1038/srep20205. Sci Rep. 2016. PMID: 26830979 Free PMC article.
-
Advances in novel therapeutic approaches for periodontal diseases.BMC Oral Health. 2022 Nov 15;22(1):492. doi: 10.1186/s12903-022-02530-6. BMC Oral Health. 2022. PMID: 36380339 Free PMC article. Review.
-
Effects of timing of adjunctive systemic antibiotics on the clinical outcome of periodontal therapy: A systematic review.J Clin Exp Dent. 2020 Mar 1;12(3):e300-e309. doi: 10.4317/jced.56324. eCollection 2020 Mar. J Clin Exp Dent. 2020. PMID: 32190202 Free PMC article. Review.
-
Trends in antibiotic use and microbial diagnostics in periodontal treatment: comparing surveys of German dentists in a ten-year period.Clin Oral Investig. 2016 Nov;20(8):2203-2210. doi: 10.1007/s00784-016-1722-6. Epub 2016 Jan 22. Clin Oral Investig. 2016. PMID: 26795626
-
Mechanisms of action of systemic antibiotics used in periodontal treatment and mechanisms of bacterial resistance to these drugs.J Appl Oral Sci. 2012 May-Jun;20(3):295-309. doi: 10.1590/s1678-77572012000300002. J Appl Oral Sci. 2012. PMID: 22858695 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous